Target intelligence / Profile preview

Bacterial and fungal cell membrane and biofilm matrix

Molecular classification
Other, Cell wall, Lipid bilayer, Extracellular matrix
01

Overview

Bacterial and fungal cell membranes are primarily phospholipid bilayers, often surrounded by complex cell walls (peptidoglycan in bacteria, chitin and β-glucans in fungi) that provide structural integrity, shape, and protection. In many environments—especially during chronic infection—bacteria and fungi can form biofilms, which are communities of cells embedded in a self-produced biofilm matrix. This matrix is mainly composed of extracellular polymeric substances (EPS), including polysaccharides, proteins, lipids, and extracellular DNA. The biofilm matrix protects microbes from environmental hazards, including antibiotics, and is a major contributor to persistent infections and drug resistance. Major matrix components include β-1,3 glucan and mannan in fungi, and curli, cellulose, and sometimes flagella in bacterial biofilms. The drug resistance attributed to biofilms is a consequence of both the physical barrier of the matrix and altered microenvironmental conditions within biofilms. Disrupting these structures is a key strategy for treating chronic and device-associated infections.

Other names
microbial cell membranemicrobial biofilm matrixextracellular polymeric substance (EPS)microbial cell envelopefungal cell wallbacterial cell wallbacterial extracellular matrixbiofilm EPS
02

Mechanism of action

Disruption of cell membrane integrity; Inhibition of cell wall synthesis; Interference with extracellular matrix and biofilm formation; Promotion of matrix degradation/dispersal

03

Biological functions

Barrier to environmental threatsMaintenance of cell shape and integrityRegulation of transport and exchangeStructural supportBiofilm formation and adhesionDrug resistanceImmune evasion
04

Disease associations

InfectionAntibiotic resistanceChronic inflammationOther
05

Safety considerations

Off-target effectsCytotoxicity with broad-spectrum membrane-active agentsIncomplete eradication leading to resistanceImmunopathology due to biofilm disruption and release of pathogen products
06

Interacting drugs

Echinocandins

5 more in the full profile.

07

Biomarkers

β-1,3 glucanChitinCurliExtracellular DNA

Beyond the preview

Go deeper on Bacterial and fungal cell membrane and biofilm matrix.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial and fungal cell membrane and biofilm matrix.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call